MAPT and Alzheimer disease: Only one twin study has investigated the heritability of AD plasma biomarkers and found that about half of the variance in amyloid beta (Aβ)42 and Aβ40 was explained by additive genetic effects, whereas Aβ42/40 had zero heritability; also plasma total tau had 50% heritability.4